Repository logo
 

Ivermectin-induced fixed drug eruption: a rare adverse even

Simple item page
dc.creatorMejía de Calona, Alicia
dc.creatorHenríquez Rivas, Odessa
dc.date2024-04-30
dc.date.accessioned2025-11-05T16:21:11Z
dc.date.available2025-11-05T16:21:11Z
dc.descriptionOn January 2021, a 62-year-old woman complained of “allergy” in her forearm. She had taken generic ivermectin (IVM) 6mg per week as COVID-19 prophylaxis for two weeks before the eruption. She stopped the medication and improved, but symptoms reactivated after IVM was restarted (A). On examination, there was a 4 cm diameter erythematous violaceous plaque. There was improvement after treatment with oral prednisolone and topical betamethasone (B & C). The patient had presented paracetamol-related eruption in her tongue some years before. Physicians should be aware of ivermectin-induced fixed drug eruption, since this drug is being widely used during the COVID-19 pandemic.en-US
dc.descriptionOn January 2021, a 62-year-old woman complained of “allergy” in her forearm. She had taken generic ivermectin (IVM) 6mg per week as COVID-19 prophylaxis for two weeks before the eruption. She stopped the medication and improved, but symptoms reactivated after IVM was restarted (A). On examination, there was a 4 cm diameter erythematous violaceous plaque. There was improvement after treatment with oral prednisolone and topical betamethasone (B & C). The patient had presented paracetamol-related eruption in her tongue some years before. Physicians should be aware of ivermectin-induced fixed drug eruption, since this drug is being widely used during the COVID-19 pandemic.es-ES
dc.formatapplication/pdf
dc.identifierhttps://revistas.unitec.edu/innovare/article/view/153
dc.identifier.urihttps://repositorio.unitec.edu//handle/123456789/13890
dc.languageeng
dc.publisherUniversidad Tecnológica Centroamericanaes-ES
dc.relationhttps://revistas.unitec.edu/innovare/article/view/153/138
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0es-ES
dc.sourceInnovare Revista de ciencia y tecnología; Vol. 10 No. 1 (2021); 36en-US
dc.sourceInnovare Revista de ciencia y tecnología; Vol. 10 Núm. 1 (2021); 36es-ES
dc.source2310-290X
dc.titleIvermectin-induced fixed drug eruption: a rare adverse evenen-US
dc.titleEritema fijo medicamentoso inducido por ivermectina: un evento adverso raroes-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Files

Collections

Innovare